From Casetext: Smarter Legal Research

United States v. Galbreth

UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF MISSISSIPPI SOUTHERN DIVISION
Nov 19, 2020
CAUSE NO. 1:17-CR-65-LG-RHW (S.D. Miss. Nov. 19, 2020)

Opinion

CAUSE NO. 1:17-CR-65-LG-RHW

11-19-2020

UNITED STATES OF AMERICA v. BRIAN GALBRETH


ORDER DENYING MOTION FOR COMPASSIONATE RELEASE

BEFORE THE COURT is the [64] Motion for Compassionate Release filed by the defendant, Brian Galbreth. The Government has filed an opposition to the Motion, and Galbreth has filed a reply. Having considered the submissions of the parties, the record in this matter, and the applicable law, the Court finds that Galbreth's Motion should be denied.

DISCUSSION

On November 11, 2018, Galbreth pled guilty to one count of possession of methamphetamine with intent to distribute. He was sentenced to 360 months' imprisonment, 5 years' supervised release, a $20,000 fine with interest waived, and a special assessment of $100. He is currently serving his sentence at Yazoo City Medium FCI and is set to be released on May 31, 2043.

On August 21, 2020, Galbreth filed a pro se Motion for Compassionate Release with this Court. He bases his Motion on the ongoing COVID-19 pandemic, claiming that his health places him in the high-risk category of persons subject to severe illness or death. Specifically, he cites his Type 2 diabetes, high blood pressure, and obesity as risk factors. In addition, his Motion notes that he had been exposed to COVID-19 in the facility in which he is housed and was never tested. He also asserts that the officers at the facility used face masks first, then gave the masks to the inmates. The Government opposes Galbreth's Motion, arguing (1) that Galbreth has failed to present any "extraordinary and compelling reasons" warranting a sentence reduction, and (2) that the Section 3553(a) factors strongly weigh against his release.

As an initial matter, the Court finds that Galbreth has exhausted his administrative remedies. See 18 U.S.C. § 3582(c)(1)(A); see also United States v. Kennedy, No. 1:18cr154, 2020 WL 3316993, at *2 (S.D. Miss. June 18, 2020). To the extent Galbreth requests the Court modify his sentence to home confinement, the Court lacks the authority to order home confinement. See 18 U.S.C. § 3621(b); see also United States v. Adcock, No. 3:19-CR-00106, 2020 WL 2043811, at *3 (W.D. La. Apr. 28, 2020). As to Galbreth's request for a sentence reduction, a court can reduce a sentence "if it finds that extraordinary and compelling reasons warrant such a reduction" and "that such a reduction is consistent with applicable policy statements issued by the Sentencing Commission." 18 U.S.C. § 3582(c)(1)(A). The Court also must consider the factors set forth in 18 U.S.C. § 3553(a), to the extent they are applicable. See 18 U.S.C. § 3582(c)(1)(A). The Sentencing Commission has not issued a relevant policy since the First Step Act amended 18 U.S.C. § 3582(c)(1)(A) to permit defendants to file motions for compassionate release. Regardless, the Court finds that the former policy statement continues to provide helpful guidance for determining whether a defendant is entitled to compassionate release.

Prior to enactment of the First Step Act, only the Bureau of Prisons could file motions for compassionate release.

In this case, Galbreth has not presented extraordinary and compelling reasons as set forth under the relevant policy statement. See U.S.S.G. § 1B1.13; see also 18 U.S.C. § 3142(g). As previously noted, Galbreth, a 41-year-old male, cites his Type 2 diabetes, high blood pressure, and obesity as making him particularly vulnerable to serious illness or death from COVID-19. As discussed in the Fifth Circuit's decision of United States v. Rivas, the policy statement requires additional factors to be examined when a defendant is not suffering from a terminal illness. No. 20-10360, 2020 WL 6437288, at *3 (5th Cir. Nov. 2, 2020) (citing U.S.S.G. § 1B1.13 cmt. n.1(A)(ii)). Absent evidence of a terminal illness, the factors under the policy statement must "'substantially diminish[] the ability of the defendant to provide self-care within the environment of a correctional facility and from which he or she is not expected to recover.'" Rivas, 2020 WL 6437288, at *3 (citing U.S.S.G. § 1B1.13 cmt. n.1(A)(ii)). Galbreth fails to demonstrate how his conditions substantially diminish his ability to provide his own self-care, nor does he present evidence that he is not expected to recover. See Rivas, 2020 WL 6437288, at *3. In fact, his pro se Motion indicates that he takes "medications daily" for several of his conditions. (See Def.'s Mot., at 1, ECF No. 64; see also Medical Records, ECF No. 75). Furthermore, preexisting medical conditions that place a defendant at increased risk are not in and of themselves sufficient to establish extraordinary and compelling reasons justifying a reduction in sentence. See, e.g., United States v. Jordan, 3:92-CR-42, 2020 WL 5118052, at *6 (S.D. Miss. Aug. 31, 2020) (citation omitted); United States v. Olejniczak, No. 1:15-CR-142, 2020 WL 2846591, at *4 (W.D.N.Y. June 2, 2020).

Publications from the Centers for Disease Control and Prevention ("CDC") recognize conditions such as obesity, severe obesity, and Type 2 diabetes as increasing the risk of severe illness from COVID-19. See People with Certain Medical Conditions, Centers for Disease Control and Prevention, https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html (last visited Nov. 16, 2020). Likewise, the CDC indicates high blood pressure may also increase the risk of severe illness from COVID-19. Id.

"Terminal illness" includes a serious and advanced illness with an end of life trajectory. U.S.S.G. § 1B1.13 cmt. n.1(A)(i). "Examples include metastatic solid-tumor cancer, amyotrophic lateral sclerosis (ASL), end-stage organ disease, and advanced dementia." Id. --------

Galbreth's generalized fear of contracting COVID-19 does not justify compassionate release. See Jordan, 2020 WL 5118052, at *6 (citations omitted). In his Motion, Galbreth claims that the living conditions at Yazoo City Medium, where Galbreth is currently housed, make it impossible to avoid exposure to the virus. He argues that he has been forced to wear used face masks, and that he has been exposed to COVID-19 but was never tested. This Court has held that "'the mere existence of COVID-19 in society' and, consequently, the prison system 'cannot independently justify compassionate release, especially considering BOP's statutory role, and its extensive and professional efforts to curtail the virus's spread.'" United States v. Williams, No. 2:16-cr010, 2020 WL 4210476, at *3 (S.D. Miss. July 22, 2020) (quoting United States v. Raia, 954 F.3d 594, 597 (3d Cir. 2020)). According to the Government, the Bureau of Prisons has taken significant measures to protect the health of the inmates in its charge. See, e.g., United States v. Walker, No. 3:03- CR-30, 2020 WL 5899435, at *5 (S.D. Miss. Oct. 5, 2020) (recognizing the Bureau of Prison's "program to address COVID-19 concerns and its effects on the inmate population"). Galbreth has not shown that inmates are currently not receiving adequate medical attention if they contract the virus. See United States v. Randall, No. 11-0317-08, 2020 WL 6585659, at *4 (W.D. La. Nov. 9, 2020). Additionally, Galbreth has not set forth evidence that the inmates have been wearing used face masks recycled by the prison guards. As such, the Court finds Galbreth's concerns not an "extraordinary and compelling reason" under 18 U.S.C. § 3582(c)(1)(A) justifying his release.

The Section 3553 factors also disfavor a sentence reduction. See 18 U.S.C. § 3553(a). Galbreth pled guilty to the count listed against him in the indictment. After considering several special offense characteristics, Galbreth's total offense level was 39. The Presentence Investigation Report ("PSI") attributed Galbreth as having an aggravating role in the offense, and committed the offense as part of a pattern of criminal conduct engaged in as a livelihood. (See Present. Invest. Rep., at ¶ 61, at 15, ECF No. 43). The PSI also reflects that Galbreth has been previously convicted of several minor drug offenses, for which he served time. (See id., at ¶¶ 72-73, 77, at 16, 18, ECF No. 43). Although the sentencing guideline was 360 months to life based upon his offense and criminal history, Galbreth benefited from receiving the lower end of the recommended guideline range. (See id. at ¶ 107, at 23). The Court finds that, under these circumstances, a reduction in Galbreth's sentence would not reflect the gravity of the offense. Therefore, it cannot disturb his sentence given the circumstances surrounding his conviction.

IT IS THEREFORE ORDERED AND ADJUDGED that the [64] Motion for Compassionate Release filed by the defendant, Brian Galbreth, is hereby DENIED.

SO ORDERED AND ADJUDGED this the 19th day of November, 2020.

/s/_________

LOUIS GUIROLA, JR.

UNITED STATES DISTRICT JUDGE


Summaries of

United States v. Galbreth

UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF MISSISSIPPI SOUTHERN DIVISION
Nov 19, 2020
CAUSE NO. 1:17-CR-65-LG-RHW (S.D. Miss. Nov. 19, 2020)
Case details for

United States v. Galbreth

Case Details

Full title:UNITED STATES OF AMERICA v. BRIAN GALBRETH

Court:UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF MISSISSIPPI SOUTHERN DIVISION

Date published: Nov 19, 2020

Citations

CAUSE NO. 1:17-CR-65-LG-RHW (S.D. Miss. Nov. 19, 2020)

Citing Cases

United States v. Sherrill

To the extent Sherrill requests that the Court modify her sentence to home confinement, the Court lacks the…